Form 8-K - Current report:
SEC Accession No. 0000950123-10-063206
Filing Date
2010-07-01
Accepted
2010-07-01 17:05:21
Documents
3
Period of Report
2010-06-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K g23957e8vk.htm 8-K 11567
2 EX-99.1 g23957exv99w1.htm EX-99.1 7332
3 GRAPHIC g23957g2395700.gif GRAPHIC 6221
  Complete submission text file 0000950123-10-063206.txt   29194
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

EIN.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15875 | Film No.: 10931639
SIC: 2834 Pharmaceutical Preparations